This week's Fierce Pharma is brought to you by EY.

Hi E, check out this Fierce
Resource we think you'll like:

Mitigate Audit Risks Caused by Changes in Value Drivers

Artificial intelligence (AI) is transforming drug discovery, reshaping R&D, and shifting value across development phases.

Download Now

Download this exclusive EY whitepaper to explore:

How AI is transforming drug R&D and tax structures
Key transfer pricing considerations for AI-driven innovation
Strategies to mitigate risk and maximize tax efficiency

Download Now

You are currently subscribed as newsletter@newslettercollector.com
If you no longer wish to receive promotions from Fierce Life Sciences, simply unsubscribe.
Refer to our Privacy Policy.

Fierce Life Sciences is a division of Questex LLC.
1111B S Governors Ave, Suite 25792 Dover, DE, 19904
© 2025 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission.